Accolade Inc
NASDAQ:ACCD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/OCF
Enterprise Value to Operating Cash Flow (EV/OCF) ratio compares a company`s total enterprise value to its operating cash flow. It shows how much investors are paying for each dollar of the company`s operating cash flow, including both equity and debt.
Enterprise Value to Operating Cash Flow (EV/OCF) ratio compares a company`s total enterprise value to its operating cash flow. It shows how much investors are paying for each dollar of the company`s operating cash flow, including both equity and debt.
Valuation Scenarios
If EV/OCF returns to its Industry Average (18.7), the stock would be worth $-1.6 (123% downside from current price).
| Scenario | EV/OCF Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | -81.9 | $7.02 |
0%
|
| Industry Average | 18.7 | $-1.6 |
-123%
|
| Country Average | 16.7 | $-1.43 |
-120%
|
Forward EV/OCF
Today’s price vs future operating cash flow
Peer Comparison
| Market Cap | EV/OCF | P/E | ||||
|---|---|---|---|---|---|---|
| US |
|
Accolade Inc
NASDAQ:ACCD
|
569.9m USD | -81.9 | -3.2 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
97.3B USD | 13.9 | 55 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
69B EUR | 10.6 | 13.4 | |
| US |
|
Cigna Corp
NYSE:CI
|
73.7B USD | 0 | 12.4 | |
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
24.7B EUR | 13.1 | 19.7 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
23.1B EUR | 11.1 | 23.8 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
22.1B USD | 16.2 | 25.2 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
21.6B USD | 14 | 21.9 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
11B EUR | 6.6 | 11.3 | |
| US |
|
Guardant Health Inc
NASDAQ:GH
|
11.9B USD | -67.2 | -28.6 | |
| US |
|
DaVita Inc
NYSE:DVA
|
10.2B USD | 10.3 | 13.7 |
Market Distribution
| Min | 0 |
| 30th Percentile | 11.7 |
| Median | 16.7 |
| 70th Percentile | 23.6 |
| Max | 3 178 983.5 |
Other Multiples
Accolade Inc
Glance View
Accolade, Inc. engages in the provision of personalized health and benefits solutions. The company is headquartered in Seattle, Washington and currently employs 2,350 full-time employees. The company went IPO on 2020-07-02. The Company’s customers are primarily employers that deploy Accolade in order to provide employees and their families members a single place to turn for their health, healthcare, and benefits needs. Its platform combines open, cloud-based intelligent technology with multimodal support from a team of empathetic and knowledgeable Accolade Health Assistants and clinicians, including nurses, physician medical directors, and behavioral health specialists. The firm leverages its integrated capabilities, connectivity with providers and the healthcare ecosystem, and longitudinal data to engage across the member population. Its offerings are: Accolade Total Benefits, Accolade Total Care, Accolade Total Health and Benefits, Accolade Boost, the Trusted Supplier Program, and Mental Health Integrated Care solutions.
